KALA BIO, Inc. (KALA)Healthcare | Biotechnology | Arlington, United States | NasdaqCM
0.20 USD
+0.01
(4.082%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.20 0.00 (-0.002%) ⇩ (April 17, 2026, 7:53 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:01 p.m. EDT
KALA BIO, Inc. (KALA) has been experiencing a steep decline in its stock price over the past few months, with recent prices hovering around $0.16 to $0.23. The stock has shown a strong negative momentum, with a 50-day average change of -36.07% and a 200-day average change of -94.5%. This indicates a significant bearish trend, which is not favorable for short-term traders looking for momentum or a buy-the-dip opportunity. The recent news highlights include a failed Phase 2b trial, which likely contributed to the stock's decline, and a pivot to a revenue model with an AI platform. However, these developments do not appear to have positively impacted the stock price. The company's financials are also concerning, with negative earnings, a low current ratio, and negative book value. Given the lack of dividends and the bearish trend, KALA is not a suitable investment for short-term traders. For long-term investors, the stock's fundamentals are weak, and the company's future prospects are uncertain. Therefore, it is advisable to avoid KALA for both short-term and long-term investments. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.549711 |
| MSTL | 0.628229 |
| AutoETS | 0.637705 |
| AutoARIMA | 0.652626 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 15.44 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.268 |
| Excess Kurtosis | -1.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 184,875,872 |
| Forward P/E | -0.03 |
| Previous Name | Kala Pharmaceuticals, Inc. |
| Website | https://www.kalarx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9395137 |
| Address1 | 1,167 Massachusetts Avenue |
| All Time High | 1,337.5 |
| All Time Low | 0.146 |
| Ask | 0.2063 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 2,531,880 |
| Average Daily Volume3 Month | 6,973,591 |
| Average Volume | 6,973,591 |
| Average Volume10Days | 2,531,880 |
| Bid | 0.1951 |
| Bid Size | 4 |
| Book Value | 0.251 |
| City | Arlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.1989 |
| Current Ratio | 3.805 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.2052 |
| Day Low | 0.188 |
| Display Name | KALA BIO |
| Earnings Timestamp End | 1,754,656,200 |
| Earnings Timestamp Start | 1,754,310,600 |
| Ebitda | -42,092,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.213 |
| Enterprise Value | 177,318,880 |
| Eps Forward | -6.67 |
| Eps Trailing Twelve Months | -3.31 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 781 642 0399 |
| Fifty Day Average | 0.2881 |
| Fifty Day Average Change | -0.089200005 |
| Fifty Day Average Change Percent | -0.30961472 |
| Fifty Two Week Change Percent | -93.95137 |
| Fifty Two Week High | 20.6 |
| Fifty Two Week High Change | -20.4011 |
| Fifty Two Week High Change Percent | -0.99034464 |
| Fifty Two Week Low | 0.146 |
| Fifty Two Week Low Change | 0.0529 |
| Fifty Two Week Low Change Percent | 0.36232877 |
| Fifty Two Week Range | 0.146 - 20.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,500,557,400,000 |
| Float Shares | 867,550,259 |
| Forward Eps | -6.67 |
| Forward P E | -0.02982009 |
| Free Cashflow | -32,981,124 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.000060000002 |
| Held Percent Institutions | 0.0075499997 |
| Implied Shares Outstanding | 929,491,578 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,666,310,400 |
| Last Split Factor | 1:50 |
| Long Business Summary | KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. |
| Long Name | KALA BIO, Inc. |
| Market | us_market |
| Market Cap | 184,875,872 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_83652421 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -26,980,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 184,875,874 |
| Open | 0.1889 |
| Operating Cashflow | -31,991,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 996 5252 |
| Post Market Change | -0.0015999973 |
| Post Market Change Percent | -0.804423 |
| Post Market Price | 0.1973 |
| Post Market Time | 1,776,469,992 |
| Prev Name | Kala Pharmaceuticals, Inc. |
| Previous Close | 0.1911 |
| Price Hint | 4 |
| Price To Book | 0.79243034 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.03 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0078 |
| Regular Market Change Percent | 4.08163 |
| Regular Market Day High | 0.2052 |
| Regular Market Day Low | 0.188 |
| Regular Market Day Range | 0.188 - 0.2052 |
| Regular Market Open | 0.1889 |
| Regular Market Previous Close | 0.1911 |
| Regular Market Price | 0.1989 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,669,298 |
| Return On Assets | -0.81589997 |
| Return On Equity | -2.7918 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 929,491,578 |
| Shares Percent Shares Out | 0.0011999999 |
| Shares Short | 1,137,572 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 975,765 |
| Short Name | KALA BIO, Inc. |
| Short Percent Of Float | 0.0013 |
| Short Ratio | 0.07 |
| Source Interval | 15 |
| State | MA |
| Symbol | KALA |
| Total Cash | 7,557,000 |
| Total Cash Per Share | 0.008 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.31 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.57651 |
| Two Hundred Day Average Change | -3.37761 |
| Two Hundred Day Average Change Percent | -0.94438714 |
| Type Disp | Equity |
| Volume | 1,669,298 |
| Website | https://www.kalarx.com |
| Zip | 2,476 |